May Zhao

President / General Manager, Longer Precision Pump Co., Ltd (Halma Plc) @ Halma plc

About

Accomplished business leader with 20+ years of experience in business development, strategic marketing and operations cross over Asia Pacific region. Proven track record of business growth acceleration and organization performance improvement. Innovative thinking for new opportunities and strong execution with excellence. Strong people leadership through activating and inspiring a winning team culture, driving and enhancing talent capabilities. • General management leader with 20+ years in multinational healthcare, medical devices and specialty biotech, with senior leadership experience across China and Asia Pacific. • Proven record of scaling businesses and improving profitability: 45% revenue growth and 46% net profit uplift (FY2022); grew APAC franchise to US$180M at 35% CAGR. • End-to-end leadership across strategy, P&L, sales and marketing, portfolio/NPI and commercial transformation, manufacturing operations, quality and supply chain,. • Trusted partner to global HQ and local stakeholders; strong governance, compliance and risk management. Fluent in English; native Mandarin.

Country

China

City

Shanghai

Industry

Medical Device

Skill

Consultancy Services, Design Consulting, Organizational Consulting, Financial Consulting, Small Business Consulting, Commercialization, Product Launch, Product Marketing, Medical Devices, Market Development, Cross-functional Team Leadership, Marketing Strategy, Leadership, Pharmaceutical Industry, Strategy, Orthopedic, Business Development, Medical Sales, Market Research, Strategic Planning

Experience

President / General Manager, Longer Precision Pump Co., Ltd (Halma Plc)

Halma plc

2022-3 - 2025-10 · 3 yrs 8 mos

Shanghai, China

Led a medical and laboratory equipment manufacturing business (precision components and subsystems for life-science instruments and medical device OEMs); overall responsibility for strategy, P&L, production, operations, sales, marketing and export business. • Delivered 45% revenue growth and 46% net profit increase in FY2022; received Halma Global "Company of the Year" award. • Reshaped leadership team (National Sales Lead, Corporate Strategy Lead, VP Operations); acted as Export Business Lead. • Reorganized commercial and service functions to improve customer coverage and responsiveness; drove continuous improvement across operations. • Strengthened government relationships; awarded China MIIT "Little Giant" recognition (Aug 2023).

Asia Pacific Director, CERENOVUS (Neurovascular Interventional Device)

Johnson & Johnson MedTech

2018-9 - 2022-3 · 3 yrs 7 mos

Regional leadership covering China, Japan, Korea, ANZ, India and Southeast Asia; partnered with Sales, RA/QA and R&D to scale a high-growth franchise. • Drove APAC growth at 35% CAGR (2018-2021), reaching US$180M; largest contributor to global growth. • Accelerated China growth to 45% CAGR; China became the largest single-country contributor globally. • Accelerated multiple NPIs across APAC; strengthened KOL/advisory-board networks; activated a 270-person organization.

Marketing Director, China, Medical Pharmaceutical Systems (MPS)

2018-1 - 2018-9 · 9 mos

• Led a 30-person marketing team; delivered 10% growth in a highly competitive market (75+ competitors). • Built pricing strategy and execution plan for Volume-Based Procurement (VBP); partnered with global sourcing and local R&D to accelerate NPIs.

Associate Marketing Director, Neurovascular, Neurosurgery, CMF

Johnson & Johnson MedTech

2016-1 - 2018-1 · 2 yrs 1 mo

Shanghai, China

• Led China marketing team to deliver 35%-50% growth through NPI acceleration and portfolio execution. • Built national KOL engagement platform; coordinated with partners for tailored solutions and cross-border initiatives.

Asia Pacific Marketing Manager, CMF, Neurovascular, Neurosurgery

Johnson & Johnson MedTech

2009-6 - 2015-12 · 6 yrs 7 mos

• Drove business at 30% CAGR (2009-2015) through portfolio strategy and regional go-to-market execution. • Facilitated value-product development in Japan with local KOLs and global R&D; strengthened clinical education and adoption.

Marketing Manager, Specialty Biotech

CSL

2005-1 - 2009-5 · 4 yrs 5 mos

• Drove albumin business to 100% growth each year (2005-2009); increased market share from 8% to 35% in three years. • Built dedicated product-marketing and procedure-marketing teams to scale execution and customer education.

Marketing Manager, Neurovascular interventional device

Boston Scientific

2003-3 - 2004-12 · 1 yr 10 mos

• Launched two NPIs (Matrix Coil, Neuroform Stent) and achieved 25% market share within the first year. • Established the first Center of Excellence (COE) in China to support physician training and adoption.